Loading...
Loading...
Supporting Quantech Group Ltd
Help us bring hope to people living with Type 1 & Type 2 diabetes and spinal cord injuries.
This campaign raises NZD 150,000 to fund first-in-human Phase-1 clinical feasibility trials across three indications.
The primary trial will act as the core clinical proof point, with two additional pilot cohorts to confirm cross-indication signals.
Funds will cover clinical site & investigator fees, patient recruitment, data monitoring, device preparation, insurance, regulatory costs, and operational contingency.
The goal is to generate initial human safety and efficacy data and create a clinical evidence package to unlock larger follow-on funding rounds.
📊 DETAILED TRIAL PROTOCOLS Download comprehensive information about each clinical trial:
- Type 1 Diabetes Trial Protocol: https://drive.google.com/file/d/1_QpMh1IQJBewJ7GnBGGRWSaS1VWNyesY/view?usp=drive_link
- Type 2 Diabetes Trial Protocol: https://drive.google.com/file/d/11-8id9n5Xu373BT-OAqayPMfJ4xQz_Lf/view?usp=drive_link
- Spinal Cord Injury Trial Protocol: https://drive.google.com/file/d/1fQZ0lA2qSbX5ELdBnsZedigoCij-V5fz/view?usp=drive_link
For questions about the trials or to discuss larger contributions, please contact Viktor at [email protected]
Campaign Progress








0 items
Add some items to get started!